Actavis Generic Infringed Weight Loss Pill Patent, Judge Says
A Delaware federal court ruled Friday that generic drug company Actavis Laboratories FL Inc. failed to invalidate patents held by Orexigen Therapeutics Inc. and thus infringed its weight-loss drug Contrave....To view the full article, register now.
Already a subscriber? Click here to view full article